Dr Ronan Lordan

Available to discuss new collaborations, science outreach or speaking opportunities. Feel free to make contact via email or twitter.



Institute for Translational Medicine and Therapeutics

Perelman School of Medicine, University of Pennsylvania



In vitro Anti‐atherogenic Properties of N‐Heterocyclic Carbene Aurate(I) Compounds


Journal article


Eleni Sioriki, R. Lordan, Fady Nahra, K. Van Hecke, I. Zabetakis, S. Nolan
ChemMedChem, 2018

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Sioriki, E., Lordan, R., Nahra, F., Hecke, K. V., Zabetakis, I., & Nolan, S. (2018). In vitro Anti‐atherogenic Properties of N‐Heterocyclic Carbene Aurate(I) Compounds. ChemMedChem.


Chicago/Turabian   Click to copy
Sioriki, Eleni, R. Lordan, Fady Nahra, K. Van Hecke, I. Zabetakis, and S. Nolan. “In Vitro Anti‐Atherogenic Properties of N‐Heterocyclic Carbene Aurate(I) Compounds.” ChemMedChem (2018).


MLA   Click to copy
Sioriki, Eleni, et al. “In Vitro Anti‐Atherogenic Properties of N‐Heterocyclic Carbene Aurate(I) Compounds.” ChemMedChem, 2018.


BibTeX   Click to copy

@article{eleni2018a,
  title = {In vitro Anti‐atherogenic Properties of N‐Heterocyclic Carbene Aurate(I) Compounds},
  year = {2018},
  journal = {ChemMedChem},
  author = {Sioriki, Eleni and Lordan, R. and Nahra, Fady and Hecke, K. Van and Zabetakis, I. and Nolan, S.}
}

Abstract

The anti‐atherogenic (anti‐inflammatory) properties of various aurate(I) salts, of the general formula [NHC⋅H][AuCl2] (NHC=N‐heterocyclic carbene) were investigated. The aurates were easily synthesized and obtained in analytically pure form. In addition, the biological activity of these compounds against atheromatosis via in vitro inhibition of platelet‐activating factor (PAF)‐induced platelet aggregation was probed. All complexes were found to possess anti‐aggregatory properties in vitro with [IPr*⋅H][AuCl2] (6) being the most potent inhibitor of PAF at micromolar concentration. Based on our findings, we conclude that these simply assembled aurates are a very promising class of PAF inhibitors and anti‐inflammatory drugs.


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in